STAT

SEPTEMBER 1, 2023

In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC health system received 450 doses of Evusheld — a scarce antibody cocktail being used at the time to prevent immunocompromised patients from being infected by the coronavirus. But those doses were just a fraction of a percent of what the sprawling 35-hospital system needed to protect its 200,000 immunocompromised patients.

Hospitals 142

Hospitals 142

Pharmacy Times

SEPTEMBER 1, 2023

In a previous trial, DARE-19, investigators reported that the SGLT2 inhibitor dapagliflozin did not benefit patients with COVID-19 who had cardiometabolic risk factors.

Hospitals 139

Hospitals 139

STAT

SEPTEMBER 1, 2023

The U.S. is running low on primary care physicians, with an estimated shortage of between 17,800 and 48,000 predicted by 2034. The dearth of doctors in this area has broad ramifications, ranging from more patients seeking care from specialty and emergency medicine to increased costs to the health care system  and poorer public health outcomes. One of the challenges to growing the ranks of primary care doctors is that family physicians and others in primary care typically have a much lower i

135

135

Fierce Pharma

SEPTEMBER 1, 2023

After months of legal wrangling, Amgen is free to go forward with its $27.8 billion buyout of Horizon Therapeutics. | Friday, the U.S. Federal Trade Commission (FTC) said it reached a proposed consent order with Amgen to address “the potential competitive harm” that could result from the merger deal. Now, Amgen is free to go forward with its $28 billion buyout.

128

128

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

SEPTEMBER 1, 2023

Although the pandemic has negatively influenced the care that patients with cardiovascular conditions receive, the study authors found that there were not significant inequities regarding patients’ race.

121

121

Fierce Pharma

SEPTEMBER 1, 2023

Approved two summers ago for chronic kidney disease (CKD) associated with type 2 diabetes, Bayer’s Kerendia (finerenone) isn’t off to the flying start expected of a potential blockbuster. | Bayer plans three new trials to assess its potential blockbuster medicine Kerendia in heart failure. The drug was first approved 2 years ago in CKD associated with diabetes.

124

124

Fierce Pharma

SEPTEMBER 1, 2023

After a groundbreaking approval for Tecentriq, Roche has another positive early-stage lung cancer trial to celebrate. This time, the honor belongs to a targeted therapy in Alecensa. | After a groundbreaking approval for Tecentriq, Roche has another positive early-stage lung cancer trial to celebrate. This time, the honor belongs to a targeted therapy in Alecensa.

118

118

Drug Topics

SEPTEMBER 1, 2023

The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.

Nursing Homes 98

Nursing Homes FDA 98

The Thyroid Pharmacist

SEPTEMBER 1, 2023

A few years ago, I visited with family in Poland. At that time, one of my cousins was attending dental school in the European Union. She asked me, “Izabella, is it true that the U.S. government adds fluoride to their water supply, in an effort to reduce dental cavities, instead of educating the public about the effect of sugar consumption and nutrition on health?

Compounding 115

Compounding Adverse Reactions Chemotherapy Labelling 115

STAT

SEPTEMBER 1, 2023

Eleven years ago, the Affordable Care Act codified a critical aspect of postpartum care: breastfeeding support. The hard part — the legislation — was done. Yet so far, no meaningful implementation and enforcement of this policy has occurred.

114

114

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

SEPTEMBER 1, 2023

Or Shaval, CEO of Remepy and Shahar Shelly, the company’s chief medical officer, join Editor in Chief Jonah Comstock to talk about their unorthodox approach and the science that underpins it. They discuss how their in-development products are similar and different from traditional digital therapeutics.

111

111

STAT

SEPTEMBER 1, 2023

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured. So he’s seen the field’s highs and lows.

114

114

Fierce Pharma

SEPTEMBER 1, 2023

When it comes to heart failure medication, a labeling mix-up can have dire consequences. | Marlex Pharmaceuticals of New Castle, Delaware, is recalling two lots of digoxin tablets at the 0.125-mg and 0.25-mg doses. The company is pulling the batches of heart failure medication because certain bottles of 0.125-mg digoxin tablets are mislabeled with the 0.25-mg dose, and vice versa.

Labelling 110

Labelling 110

STAT

SEPTEMBER 1, 2023

After months of legal sparring, Amgen and Horizon Therapeutics settled a lawsuit with the Federal Trade Commission that will allow the company to proceed with their planned $28 billion merger. The agreement comes after the agency challenged the deal over concerns the combined company could abuse its power to entrench the monopolies for two drugs currently sold by Horizon.

Packaging 113

Packaging Insurance 113

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Store News

SEPTEMBER 1, 2023

Sam's Club is offering a $5 in-club shopping credit for members vaccinated at a Sam’s Club pharmacy between Aug. 30 and Sept. 24, while Hy-Vee pharmacy is providing patients the ability to earn a 20-cent Hy-Vee Fuel Saver + Perks reward after vaccination.

Vaccines 109

Vaccines 109

Drug Topics

SEPTEMBER 1, 2023

A recent study found that lower vitamin k status was associated with higher rates of chronic obstructive lung disease, wheezing, and asthma.

98

98

Fierce Healthcare

SEPTEMBER 1, 2023

As more and more cell and gene therapies come to the market, these high-cost drugs are set to have a major impact on cash-strapped Medicaid programs, according to a

109

109

STAT

SEPTEMBER 1, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return later this month.

97

97

ISPE

SEPTEMBER 1, 2023

Implementing Cloud-Based Pharmaceutical Plant Management Software: Data Security Considerations Trudy Patterson Fri, 09/01/2023 - 11:06 iSpeak Blog iSpeak Implementing Cloud-Based Pharmaceutical Plant Management Software: Data Security Considerations Andreas Eschbach 1 September 2023 Cloud-based systems for plant process management (PPM) 1 deliver significant benefits in terms of access, convenience, and easy management.

Communication 98

Communication Documentation 98

Fierce Healthcare

SEPTEMBER 1, 2023

Bicycle Health announced a partnership with Albertsons Companies to make prescriptions of buprenorphine injections available to patients. | The buprenorphine extended release injections, known as Sublocade, will be available across 17 states with the goal of expanding. The virtual care provider and pharmacy's collaboration hopes to increase access to vital medications for opioid use disorder, which can be hard to come by.

98

98

Hospital Pharmacy Europe

SEPTEMBER 1, 2023

The subcutaneous anti-PD-L1 cancer immunotherapy atezolizumab (brand name Tecentriq subcutaneous (SC)) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), paving the way for its use in the NHS in England, its manufacturer Roche has announced. Offering patients a faster and more convenient treatment option, the SC injection is administered under the skin and takes seven minutes to complete – 75% quicker than the 30-60 minute duration of the IV infusion.

Chemotherapy 98

Chemotherapy Hospitals FDA 98

European Pharmaceutical Review

SEPTEMBER 1, 2023

The global mRNA-based oncology therapy market is expected to reach $2 billion by 2029, according to GlobalData. BioNTech is anticipated to lead the market with a predicted $885 million in sales, and a 44.6 percent share by 2029, the research has shown. Global mRNA-based oncology therapy market At present, the pharmaceutical industry is still awaiting the first regulatory approval of an mRNA-based oncology therapy. mRNA stability and delivery specificity are two of the main obstacles hindering pr

Immunization 97

Immunization Vaccines 97

PharmaVoice

SEPTEMBER 1, 2023

Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery route holds promise for far more drugs.

105

105

Drug Store News

SEPTEMBER 1, 2023

Four weeks of anniversary deals start Sept. 1 and run through Sept. 28, with new products and promotions each week, both in-store and online.

105

105

Pharmaceutical Technology

SEPTEMBER 1, 2023

Novo Nordisk's obesity drugs are driving Danish growth as well as record profits as the company becomes second-most valuable in Europe.

105

105

Drug Store News

SEPTEMBER 1, 2023

Inspired by the realm of enchantment and mystery, the collection is the brand’s first line of shimmering and shifting magnetic nail polishes.

105

105

Pharmaceutical Technology

SEPTEMBER 1, 2023

Otsuka Pharmaceutical has signed a definitive arrangement agreement to acquire Mindset Pharma, in an all-cash deal worth C$80m ($59.1m).

105

105

Drug Store News

SEPTEMBER 1, 2023

The program will consist of a community of college ambassadors and a subset of campus reps who will play a part in furthering Bubble’s ethos.

98

98

Pharmaceutical Technology

SEPTEMBER 1, 2023

As per GlobalData, AbbVie has remained the Crohn’s disease market leader over the last five years, with Humira sales of $2.7bn in 2022 in 8MM.

98

98

Fierce Healthcare

SEPTEMBER 1, 2023

Rosalind Brewer will step down as CEO of Walgreens, kicking off the search for her replacement, the pharmacy chain announced Friday morning.

98

98

BioPharm

SEPTEMBER 1, 2023

The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market.

98

98

Pharmacy Times

SEPTEMBER 1, 2023

Heart health may influence long-term brain health as early as middle age.

123

123

OctariusRx

SEPTEMBER 1, 2023

Happy Labor Day Weekend 2023 from all of us at OctariusRx! This weekend is not the unofficial end of Summer, it’s a holiday that celebrates the millions of hardworking Americans whose work ethic, determination and achievements create the foundation for our everyday lives. Thank you to our team members, our clients, and vendors for your hard work. We appreciate all your efforts throughout the year; enjoy this extra day of rest.

82

82

European Pharmaceutical Review

SEPTEMBER 1, 2023

Roche’s Alecensa ® (alectinib) is the first anaplastic lymphoma kinase (ALK) inhibitor to demonstrate a reduction in the risk of disease recurrence or death for patients with early-stage ALK-positive non-small cell lung cancer (NSCLC) in a Phase III trial. The Phase III ALINA study compared Alecensa to platinum-based chemotherapy. Results from the trial “provide evidence for the first time that this medicine could also play a pivotal role in early-stage disease where there is significant u

Chemotherapy 80

Chemotherapy 80